Skip to content

Lysophosphatidylcholine acyltransferase 2 (LPCAT2)

Homo sapiens — UniProt Q7L5N7

Gene: LPCAT2Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Lysophosphatidylcholine acyltransferase 2 (LPCAT2) is a protein from Homo sapiens identified by UniProt accession Q7L5N7, 544 residues long. MolForge cross-references it against 0 known binders and 91 disease associations.

  • UniProt accession: Q7L5N7; gene symbol LPCAT2.
  • Organism: Homo sapiens.
  • Length: 544 amino acids.
  • Top disease associations (Open Targets): Torg-Winchester syndrome, multicentric osteolysis-nodulosis-arthropathy spectrum and hormone measurement.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameLysophosphatidylcholine acyltransferase 2
UniProt accessionQ7L5N7
GeneLPCAT2
OrganismHomo sapiens
Length544 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (91)

Diseases linked to this target (Open Targets).

  • Torg-Winchester syndrome · score 0.33
  • multicentric osteolysis-nodulosis-arthropathy spectrum · score 0.33
  • hormone measurement · score 0.23
  • thyroxine measurement · score 0.23
  • tuberculosis · score 0.21
  • glioblastoma multiforme · score 0.18
  • heel bone mineral density · score 0.16
  • body height · score 0.15
  • bone quantitative ultrasound measurement · score 0.14
  • age-related hearing impairment · score 0.12

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q7L5N7-F1alphafoldPREDICTED81.60—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q7L5N7.

Amino-acid sequence (544 residues)

MSRCAQAAEV AATVPGAGVG NVGLRPPMVP RQASFFPPPV PNPFVQQTQI GSARRVQIVL LGIILLPIRV LLVALILLLA WPFAAISTVC CPEKLTHPIT GWRRKITQTA LKFLGRAMFF SMGFIVAVKG KIASPLEAPV FVAAPHSTFF DGIACVVAGL PSMVSRNENA QVPLIGRLLR AVQPVLVSRV DPDSRKNTIN EIIKRTTSGG EWPQILVFPE GTCTNRSCLI TFKPGAFIPG VPVQPVLLRY PNKLDTVTWT WQGYTFIQLC MLTFCQLFTK VEVEFMPVQV PNDEEKNDPV LFANKVRNLM AEALGIPVTD HTYEDCRLMI SAGQLTLPME AGLVEFTKIS RKLKLDWDGV RKHLDEYASI ASSSKGGRIG IEEFAKYLKL PVSDVLRQLF ALFDRNHDGS IDFREYVIGL AVLCNPSNTE EIIQVAFKLF DVDEDGYITE EEFSTILQAS LGVPDLDVSG LFKEIAQGDS ISYEEFKSFA LKHPEYAKIF TTYLDLQTCH VFSLPKEVQT TPSTASNKVS PEKHEESTSD KKDD

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with LPCAT2?

The strongest Open Targets associations for LPCAT2 are Torg-Winchester syndrome, multicentric osteolysis-nodulosis-arthropathy spectrum, hormone measurement, thyroxine measurement and tuberculosis.

How long is the LPCAT2 protein?

The Homo sapiens LPCAT2 protein (UniProt Q7L5N7) is 544 amino acids long.

Browse: Targets: L · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Lysophosphatidylcholine acyltransferase 2 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ7L5N7
GeneLPCAT2
OrganismHomo sapiens
Length544
Binders0
Diseases91
View on UniProt